NCCN Clinical Practice Guidelines in Oncology Breast Cancer (PDF: 748K)
Dates and Times
End Date: 3/27/2012
ObjectivesUpon completion of this educational activity, the participant should be able to: 1.) Review the indications for prescribing bisphosphonates for bone loss in women with breast cancer. 2.) Review the anit-tumor effects of Bisphophonates in the adjuvant setting.
PDF of Slides
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.